Metabolic pathology of autism in relation to redox metabolism
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2014/03/01
-
Journal
-
Indian UGC (journal)
-
Refrences77
-
Citations76
-
Richard E Frye Arkansas Children's Hospital Research Institute, Department of Pediatrics, University of Arkansas for Medical Sciences, Slot 512-41B, 13 Children's Way, Little Rock, AR 72202, USA
-
S Jill James Arkansas Children's Hospital Research Institute, Department of Pediatrics, University of Arkansas for Medical Sciences, Slot 512-41B, 13 Children's Way, Little Rock, AR 72202, USA
Abstract
Cite
Frye, Richard E, and S Jill James. “Metabolic Pathology of Autism in Relation to Redox Metabolism”. Biomarkers in Medicine, vol. 8, no. 3, 2014, pp. 321-30, https://doi.org/10.2217/bmm.13.158.
Frye, R. E., & James, S. J. (2014). Metabolic pathology of autism in relation to redox metabolism. Biomarkers in Medicine, 8(3), 321-330. https://doi.org/10.2217/bmm.13.158
Frye, Richard E, and S Jill James. “Metabolic Pathology of Autism in Relation to Redox Metabolism”. Biomarkers in Medicine 8, no. 3 (2014): 321-30. https://doi.org/10.2217/bmm.13.158.
Frye RE, James SJ. Metabolic pathology of autism in relation to redox metabolism. Biomarkers in Medicine. 2014;8(3):321-30.
Journal Categories
Medicine
Medicine (General)
Science
Biology (General)
Genetics
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Title | Pediatric Research |
| 2011 | |
| Title | 2010 | |||
| Title | 2009 | |||
| Title | 2012 | |||
| Title | 2011 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Seeing beyond words: Visualizing autism spectrum disorder biomarker insights | Heliyon | 2024 | ||
Adiponectin blood levels and autism spectrum disorders: a systematic review | BMC Psychiatry |
| 2024 | |
| Oxidative stress and neuroimmune proteins in a mouse model of autism | Cell Stress & Chaperones |
| 2023 | |
Treatment of Autism Spectrum Disorders by Mitochondrial-targeted
Drug: Future of Neurological Diseases Therapeutics | Current Neuropharmacology |
| 2023 | |
A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers,
Pharmacological and Non-Pharmacological Interventions | CNS & Neurological Disorders - Drug Targets |
| 7 | 2023 |
Citations Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 23
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Potential Biomarkers for Diagnosis and Screening of Autism Spectrum Disorders and was published in 2014. The most recent citation comes from a 2024 study titled Seeing beyond words: Visualizing autism spectrum disorder biomarker insights. This article reached its peak citation in 2017, with 12 citations. It has been cited in 62 different journals, 27% of which are open access. Among related journals, the Scientific Reports cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.